93326 ⎘
Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
#2PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
#3Pyruvate kinase activators for use in therapy
#4Compositions for the treatment of pulmonary fibrosis
#5PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
#6Compositions for the treatment of pulmonary fibrosis
#7Processes and intermediates for making sweet taste enhancers
#8Prodrugs of phenolic TRPV1 agonists
#9Processes and intermediates for making sweet taste enhancers
#10Pyruvate kinase activators for use in therapy
#11Sulfonylaminobenzamide compounds as anthelmintics
#12Inhibitors of human immunodeficiency virus replication
#13Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease
#14TETRACYCLINE COMPOUNDS
#15Processes and intermediates for making sweet taste enhancers
#16Pyruvate kinase activators for use in therapy
#17Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof
#18Processes and intermediates for making sweet taste enhancers
#19Compositions for the treatment of hypertension and/or fibrosis
#20Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#21Compounds and compositions for use a modulators of tau aggregation and alleviation of tauopathies
#22Processes and intermediates for making sweet taste enhancers
#23Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
#24Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt
#25COMPOUNDS AND COMPOSITIONS FOR USE AS MODULATORS OF TAU AGGREGATION AND ALLEVIATION OF TAUOPATHIES
#26Methods and compositions for treatment of cancer and autoimmune disease
#27CARBONIC ANHYDRASE INHIBITORS
#28Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#29CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#30Substituted benzosulphonamides
#31Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
#32BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
#33Tetracycline compounds
#34Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders
#35Processes and intermediates for making sweet taste enhancers
#36Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#37SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY
#38SUBSTITUTED PHENOXYBENZAMIDES
#39INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#40Branched surfactant having fluoroalkyl group and hydrocarbon group
#41COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#42Certain Chemical Entities, Compositions, and Methods
#43Substituted arylalkanoic acid derivatives and use thereof
#44Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
#45BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS
#46Imidazopyridinyl benzamide mitotic kinesin inhibitors
#47Imidazopyridinyl benzamide mitotic kinesin inhibitors
#48CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#49TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
#50BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
#51Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
#52Substituted arylalkanoic acid derivatives and use thereof
#532,3,4,5-tetrahydroxy-6-sulfooxy hexanoic acid, pharmaceutically acceptable salts and equilibrium forms thereof, processes for their preparation, pharmaceutical compositions comprising such compounds and their medical use
#54Certain chemical entities, compositions, and methods
#55Branched surfactant having fluoroalkyl group and hydrocarbon group
#56MATRIX METALLOPROTEASE INHIBITORS
#57Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
#58Inhibitors of Histone Deacetylase
#59N-aryl-N'alkyl sulfamides as MEK inhibitors
#60Substituted arylalkanoic acid derivatives and use thereof
#61Imidazoyl-benzamide anti-cancer agents
#62Compounds, compositions and methods
#63CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION
#64N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
#65Tricyclic steroid hormone nuclear receptor modulators
#66Phenethanolamine derivatives
#67Cycloalkyl inhibitors of potassium channel function
#682,3-Oxidosqualene-lanosterol cyclase inhibitors
#692-aryl-propionic acids and pharmaceutical compositions containing them